Arcadia Biosciences
RKDA
15 hedge funds and large institutions have $431K invested in Arcadia Biosciences in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 0 closing their positions.
172% more capital invested
Capital invested by funds: $159K → $431K (+$273K)
25% more funds holding
Funds holding: 12 → 15 (+3)
8.22% more ownership
Funds ownership: 4.27% → 12.5% (+8.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$202K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$43.9K |
| 3 |
VF
Virtu Financial
New York
|
+$35.6K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.78K |
| 5 |
JP Morgan Chase
New York
|
+$1.59K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $305K | +$202K | +64,600 | +198% |
|
|
2
Vanguard Group
Malvern,
Pennsylvania
| $43.9K | +$43.9K | +14,038 | New |
|
3
State Street
Boston,
Massachusetts
| $36.8K | – | – | – |
|
|
VF
4
Virtu Financial
New York
| $34K | +$35.6K | +11,370 | New |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $9.01K | +$1.78K | +568 | +25% |
|
|
6
JP Morgan Chase
New York
| $1.54K | +$1.59K | +508 | New |
|
7
Morgan Stanley
New York
| $1.3K | +$648 | +207 | +100% |
|
8
BlackRock
New York
| $119 | – | – | – |
|
9
Group One Trading
Chicago,
Illinois
| $55 | – | – | – |
|
10
Wells Fargo
San Francisco,
California
| $28 | +$3 | +1 | +13% |
|
11
US Bancorp
Minneapolis,
Minnesota
| $16 | – | – | – |
|
|
OLVIG
12
Oliver Lagore Vanvalin Investment Group
Flint,
Michigan
| $13 | – | – | – |
|
|
HI
13
Harbour Investments
Madison,
Wisconsin
| $3 | – | – | – |
|
RKDA Hedge Fund Activity: Q4 2023 in Review
15 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Arcadia Biosciences (RKDA) for Q4 2023, worth a combined $431K — up 172% from $159K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new RKDA positions and 0 closed out — a net gain of 3 holders — while 4 added to existing stakes and 0 trimmed.
The largest buyer was Sabby Management, adding an estimated $202K.
- 15 institutional investors held Arcadia Biosciences (RKDA) as of Q4 2023, up from 12 in Q3 2023.
- Funds reported $431K of Arcadia Biosciences stock for Q4 2023, up 172% quarter-over-quarter.
- 3 funds opened new Arcadia Biosciences positions in Q4 2023 and 0 closed out, a net change of +3 holders.
- The largest Arcadia Biosciences buyer in Q4 2023 was Sabby Management, an estimated $202K added.
Based on aggregated 13F filings for Q4 2023.